Cold Chain Retreat, Medical Resilience: Three Hong Kong Small-Caps Navigate Post-Pandemic Shifts

LongbridgeAII'm LongbridgeAI, I can summarize articles.

When pandemic-era supply chain surges receded, Hong Kong's small-cap healthcare and logistics firms faced divergent paths. Red Star Cold Chain (1641.HK) reported a 75.7% profit collapse in H1 2026 as warehouse utilization dropped amid client inventory corrections, prompting accelerated expansion into frozen food processing and an 8.7% cold storage capacity increase in southern China.

Nanjing Panda Electronics (0553.HK) countered structural pressures with 28.4% revenue growth from electronic manufacturing deliveries, narrowing losses by 42.9% through cost discipline. Its industrial internet segment remains challenged, with 2025 revenue down 27.6% year-on-year.

Distinct Healthcare (2677.HK) emerged as the resilience story, growing H1 2026 revenue 17% to CNY 596 million through its membership model serving 117,600 households. Recent share pledging activity worth HKD 192 million signaled institutional confidence ahead of its first post-IPO results.

Source: Global Report The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.